Literature DB >> 3927370

The aluminum-induced increase in blood-brain barrier permeability to delta-sleep-inducing peptide occurs throughout the brain and is independent of phosphorus and acetylcholinesterase levels.

W A Banks, A J Kastin.   

Abstract

The effect of aluminum on levels of inorganic phosphorus and acetylcholinesterase in blood and brain and on permeability of the blood-brain barrier (BBB) in different regions of the brain to the neuropeptide delta-sleep-inducing peptide (DSIP) was studied in adult rats. Aluminum (100 mg/kg) significantly increased the permeability of the BBB to intracarotid 125I-N-Tyr-DSIP so that levels of radioactivity in whole brain were 45% higher than in control animals. The pattern of regional distribution of radioactivity in the brain was, however, unaffected, demonstrating that the affect of aluminum occurs throughout the BBB. Aluminum also significantly decreased inorganic phosphorus levels in the serum by 19%, but this effect did not correlate with BBB permeability to DSIP. Aluminum did not decrease brain levels of phosphorus despite the drop in blood levels of phosphorus nor affect brain or blood levels of acetylcholinesterase. Experiments with radioactive 32P reinforced the finding that blood but not brain levels of phosphorus are reliably affected by aluminum. The lack of correlation between changes in BBB permeability and decreased levels of inorganic phosphorus in the blood suggests that the effect of aluminum may not be mediated by its effects on phosphorus metabolism. Also, the change in BBB permeability after administration of aluminum does not appear to depend on changes in brain cholinergic activity but does occur throughout the brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927370     DOI: 10.1007/bf00431689

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  5 in total

1.  Behavioral changes in rats after chronic aluminum and parathyroid hormone administration.

Authors:  R L Commissaris; J J Cordon; S Sprague; J Keiser; G H Mayor; R H Rech
Journal:  Neurobehav Toxicol Teratol       Date:  1982 May-Jun

Review 2.  Dietary aluminum and Alzheimer's disease--a review.

Authors:  W O Caster; M Wang
Journal:  Sci Total Environ       Date:  1981-01       Impact factor: 7.963

3.  Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.

Authors:  D R Crapper; S Quittkat; S S Krishnan; A J Dalton; U De Boni
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

4.  Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

Authors:  I Alafuzoff; R Adolfsson; G Bucht; B Winblad
Journal:  J Neurol Sci       Date:  1983 Aug-Sep       Impact factor: 3.181

Review 5.  Senile dementia and Alzheimer's disease: a current view.

Authors:  U De Boni; D R McLachlan
Journal:  Life Sci       Date:  1980-07-07       Impact factor: 5.037

  5 in total
  3 in total

Review 1.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

2.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 3.  Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients.

Authors:  Jean-Philippe Dales; Sophie Desplat-Jégo
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.